Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-26

FDA Approved: TROPHAMINE — Supplemental Application (B. Braun Medical Inc.)

View source ↗

Summary

FDA approved a supplemental application for TROPHAMINE from B. Braun Medical Inc., authorizing changes to its approved use/label for parenteral nutrition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROPHAMINE (Amino acid injection solution for parenteral nutrition (essential amino acids with taurine))

Snippet

SUPPL AP for TROPHAMINE (ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE)